Surface is developing antibodies that target key components of the Tumor Microenvironment
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
Careers at Surface
Culture counts. Surface Oncology’s science isn’t the only thing that sets it apart.